Our Pricing

Understanding Ozempic Or Mounjaro Costs

Understanding ozempic or mounjaro costs uk pharmacy pricing helps you make informed decisions about weight loss treatment. At Cured Pharmacy, Mounjaro starts from £135.00 with transparent upfront pricing, free clinical consultation by UK prescribers, and guaranteed discreet delivery. Both medications require prescription approval following a comprehensive online assessment.

How Mounjaro And Ozempic Work Differently

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA in the UK for weight management [1]. This dual-action mechanism activates two natural hormone pathways that regulate appetite, blood glucose, and energy expenditure. Ozempic contains semaglutide, a single GLP-1 receptor agonist originally licensed for type 2 diabetes management, though it's prescribed off-label for weight loss in the UK.

In the SURPASS-3 clinical trial, participants taking the highest Mounjaro dose achieved an average 22.5% body weight reduction over 72 weeks [1]. The STEP trials demonstrated that semaglutide produced an average 14.9% weight loss over 68 weeks [2]. Both medications require weekly subcutaneous injection and work best alongside dietary modification and increased physical activity.

Your UK prescriber will evaluate your medical history, current medications, BMI, and weight loss goals to determine which treatment may be most suitable. Factors including previous treatment response, side effect tolerance, and cost considerations all influence the clinical decision.

Ozempic Or Mounjaro Costs UK Pharmacy Breakdown

At Cured Pharmacy, Mounjaro (tirzepatide) KwikPen starts from £135.00 offering competitive UK pricing with transparent costs displayed before your consultation. The final price depends on your prescribed dose strength, which your UK prescriber determines based on your clinical assessment and treatment progression.

Ozempic is not currently stocked at Cured Pharmacy, as Wegovy (the same active ingredient, semaglutide, but licensed specifically for weight management) provides a more appropriate regulatory option for weight loss treatment. Wegovy starts from £135.00 and offers similar clinical benefits to Ozempic with proper licensing for obesity management in the UK.

All prices at Cured Pharmacy include your medication, free online consultation with a UK-registered prescriber, and discreet home delivery. There are no hidden consultation fees or subscription charges — you see the complete cost upfront before starting your assessment.

What Affects Your Treatment Cost

Dose strength significantly impacts pricing, as higher-strength pens contain more active medication. Treatment typically begins at the lowest dose to minimise side effects, with gradual increases every four weeks until reaching your maintenance dose. Most patients require ongoing treatment to maintain weight loss, making long-term cost an important consideration.

Your UK prescriber may recommend starting with a lower-cost option like Saxenda (from £135.00) or Wegovy to assess your tolerance to GLP-1 medications before progressing to Mounjaro. This stepped approach can reduce initial costs whilst establishing whether injectable weight loss treatment suits you.

Clinical Evidence: Mounjaro Vs Semaglutide-Based Treatments

The SURPASS trial programme demonstrated tirzepatide's superior weight loss outcomes compared to semaglutide in head-to-head comparisons [3]. In SURPASS-2, participants taking tirzepatide 15mg lost an average of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks — nearly double the weight reduction [3].

Both medications work by slowing gastric emptying, reducing appetite, and improving glucose metabolism. Clinical trials show that approximately 89% of patients on the highest Mounjaro dose achieved at least 5% body weight reduction, whilst 57% achieved 20% or greater weight loss [1]. For semaglutide, 86.4% of participants achieved at least 5% weight loss in the STEP-1 trial [2].

Side effects are similar for both medications, with nausea, diarrhoea, constipation, and abdominal discomfort being most common during dose escalation. These gastrointestinal effects typically diminish after several weeks as your body adjusts to treatment. Your UK prescriber will monitor your progress and adjust dosing to optimise both efficacy and tolerability.

Real-World Treatment Outcomes

Clinical trial results represent controlled conditions, but real-world evidence increasingly supports similar outcomes when patients maintain treatment adherence. Success requires commitment to dietary changes, regular physical activity, and consistent weekly injections. Most UK prescribers recommend at least 12-16 weeks of treatment before evaluating full response.

Weight loss typically accelerates during the first 20-24 weeks of treatment, then continues at a slower rate. Patients who discontinue treatment often experience weight regain, which is why ongoing treatment and lifestyle modification remain essential for sustained results.

Alternative Weight Loss Treatments At Cured Pharmacy

Wegovy (semaglutide) offers a licensed alternative to Ozempic specifically approved for weight management in the UK. As the same active ingredient in a weight-loss-specific formulation, Wegovy provides regulatory compliance whilst delivering comparable clinical outcomes to off-label Ozempic use.

Saxenda (liraglutide) represents an earlier-generation GLP-1 receptor agonist requiring daily rather than weekly injection. Whilst less convenient than weekly options, Saxenda suits patients who prefer starting with a shorter-acting medication or who have experienced side effects with longer-acting alternatives.

Orlistat-based treatments including Xenical, Orlos, and Alli work through a completely different mechanism by blocking fat absorption in the digestive system. These oral medications suit patients who prefer not to inject or who have contraindications to GLP-1 treatments. Orlistat requires strict adherence to a low-fat diet to minimise gastrointestinal side effects.

How To Start Treatment At Cured Pharmacy

Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers review every assessment individually — there are no automated approvals.

If your prescriber approves treatment, your medication ships from our UK pharmacy with 100% discreet packaging. Delivery typically arrives within 2-3 working days via tracked courier. Your package includes full patient information leaflets, injection instructions, and sharps disposal guidance.

Follow-up assessments ensure your treatment remains safe and effective. Your prescriber will request progress updates at regular intervals, adjusting your dose as needed to optimise weight loss whilst minimising side effects. You can contact our clinical team at (+44) 116 4646009 with any questions during your treatment journey.

What To Expect During Your First Month

Most patients start at the lowest available dose to allow their body to adjust gradually. Mild nausea, reduced appetite, and occasional digestive changes are common during the first 2-4 weeks but typically resolve as treatment continues. Staying well-hydrated and eating smaller, more frequent meals can help manage these initial effects.

Weight loss during the first month varies considerably between individuals. Some patients notice significant appetite reduction and early weight loss, whilst others experience more gradual changes. Consistency with weekly injections and lifestyle modifications produces the best long-term outcomes.

Safety Considerations And Contraindications

Both tirzepatide and semaglutide carry contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease [4]. Your UK prescriber will screen for these conditions during your consultation to ensure treatment safety.

Patients with a history of pancreatitis, severe kidney disease, or diabetic retinopathy require careful evaluation before starting GLP-1 treatment. These medications can affect blood glucose levels, so dose adjustments of existing diabetes medications may be necessary to prevent hypoglycaemia.

Pregnancy and breastfeeding represent absolute contraindications to weight loss medication. Women of childbearing age should use reliable contraception during treatment and discontinue injections at least two months before attempting conception. Always inform your prescriber of any new symptoms or concerns during treatment.

Monitoring And Long-Term Safety

Regular monitoring helps identify any emerging issues early. Your prescriber may recommend periodic blood tests to assess kidney function, liver enzymes, and metabolic markers. Report any persistent abdominal pain, visual changes, or unusual lumps immediately, as these may indicate rare but serious complications requiring urgent medical attention.

Long-term safety data continues to accumulate as these medications remain relatively new for weight management. Current evidence from clinical trials extending beyond two years shows sustained efficacy with acceptable safety profiles when used under proper medical supervision [4].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modification, and lifestyle changes.